Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve The Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on 31st March, 2026, in accordance with Regulation 33 of the SEBI Listing\r\nRegulation.